Literature DB >> 17503265

Traditional kava beverage consumption and liver function tests in a predominantly Tongan population in Hawaii.

Amy C Brown1, Janet Onopa, Peter Holck, Pakieli Kaufusi, Derek Kabasawa, Winston J Craig, Klaus Dragull, Arieh M Levine, Jonathan D Baker.   

Abstract

PURPOSE: To determine the effects of traditionally prepared kava beverages on the liver function tests of regular kava beverage consumers in a population of Tongan and non-Tongan residents of Hawaii (Oahu).
METHODS: The liver function tests of 31 healthy adult kava drinkers were compared against a control group of 31 healthy adult non-kava drinkers. Subjects were recruited from the general population, a kava bar, and Tongan kava drinking circles. The liver function profile included AST, ALT, ALP, GGT, and bilirubin (total and direct). Other tests included total protein, albumin, and screens for viral hepatitis and hemochromatosis when indicated.
RESULTS: Chronic kava beverage consumption was associated with elevation of GGT in 65% of the kava drinkers versus 26% in the controls (P = .005). ALP was elevated in 23% of kava drinkers versus 3% in the controls (P = .053).
CONCLUSION: Heavy kava beverage consumption was associated with significantly elevated GGT levels.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17503265     DOI: 10.1080/15563650701365875

Source DB:  PubMed          Journal:  Clin Toxicol (Phila)        ISSN: 1556-3650            Impact factor:   4.467


  8 in total

1.  Pacific island 'Awa (Kava) extracts, but not isolated kavalactones, promote proinflammatory responses in model mast cells.

Authors:  Lori M N Shimoda; Christy Park; Alexander J Stokes; Henry Halenani Gomes; Helen Turner
Journal:  Phytother Res       Date:  2012-04-04       Impact factor: 5.878

2.  Kava hepatotoxicity in traditional and modern use: the presumed Pacific kava paradox hypothesis revisited.

Authors:  Rolf Teschke; Jerome Sarris; Isaac Schweitzer
Journal:  Br J Clin Pharmacol       Date:  2012-02       Impact factor: 4.335

3.  The Current Use of Sakau (Kava) in Pohnpei Island, Federated States of Micronesia.

Authors:  Moeno Sakai; Minato Nakazawa
Journal:  Hawaii J Health Soc Welf       Date:  2022-07

4.  Integrating herbs and supplements in managed care: a pharmacy perspective.

Authors:  Charles Elder; Pat Mossbrucker; Carrie M Davino-Ramaya; Ileana Bez; Margaret M Lin; Theresa A Terry; Emily A Thomas; Sean Jones
Journal:  Perm J       Date:  2008

5.  Toxicokinetics of kava.

Authors:  Anthony Rowe; Lillian Yuan Zhang; Iqbal Ramzan
Journal:  Adv Pharmacol Sci       Date:  2011-03-21

6.  Dietary feeding of Flavokawain A, a Kava chalcone, exhibits a satisfactory safety profile and its association with enhancement of phase II enzymes in mice.

Authors:  Xuesen Li; Xia Xu; Tao Ji; Zhongbo Liu; Mai Gu; Bang H Hoang; Xiaolin Zi
Journal:  Toxicol Rep       Date:  2014

Review 7.  Hepatotoxicity Induced by "the 3Ks": Kava, Kratom and Khat.

Authors:  Flaminia Pantano; Roberta Tittarelli; Giulio Mannocchi; Simona Zaami; Serafino Ricci; Raffaele Giorgetti; Daniela Terranova; Francesco P Busardò; Enrico Marinelli
Journal:  Int J Mol Sci       Date:  2016-04-16       Impact factor: 5.923

8.  Commonly Used Dietary Supplements on Coagulation Function during Surgery.

Authors:  Chong-Zhi Wang; Jonathan Moss; Chun-Su Yuan
Journal:  Medicines (Basel)       Date:  2015-07-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.